James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Only Two Months Left to Get Into iQiyi Stock, If You’ve Got the Stomach

IQ stock is apt to dish out some volatility in the meantime, but everything leads up to the pivotal date of September 25th.

3 Big Stock Charts for Wednesday: Procter & Gamble, ENSCO and Walt Disney

Stock charts of Procter & Gamble, Walt Disney and ENSCO offer traders a little of everything ... and they'll need that in this environment.

Biogen Is the Right Alzheimer’s Stock … At the Wrong Time

BIIB stock jumped on Friday, and for good reason. It's not a buy at these lofty levels, but Biogen has at least earned a spot on your watchlist.

3 Big Stock Charts for Tuesday: SBA Communications, Pfizer and Range Resources

Stock charts of SBA Communications, Range Resources and Pfizer are shaping up as the most tradeworthy bets here.

7 Small-Cap Stocks to Consider for the Second Half of 2018

Small-cap stocks have been on a tear of late. Take the hint, and start your search with these seven top prospects.